Literature DB >> 7736570

Degradation of mRNA in eukaryotes.

C A Beelman1, R Parker.   

Abstract

Based on the above mechanisms of mRNA degradation, an integrated model of mRNA turnover can be proposed (Figure 1). In this model, all polyadenylated mRNAs would be degraded by the deadenylation-dependent pathway at some rate. In addition to this default pathway, another layer of complexity would come from degradation mechanisms specific to individual mRNAs or to classes of mRNAs. Such mRNA-specific mechanisms would include sequence-specific endonuclease cleavage and deadenylation-independent decapping. Thus, the overall decay rate of an individual transcript will be a function of its susceptibility to these turnover pathways. In addition, cis-acting sequences that specify mRNA decay rate, as well as regulatory inputs that control mRNA turnover, are likely to affect all the steps of these decay pathways. One important goal in future work will be to identify the gene products that are responsible for the nucleolytic events in these pathways and to delineate how specific mRNA features act to affect the function of these degradative activities. The identification of distinct mRNA decay pathways should allow, genetic and biochemical approaches that can be designed to identify these gene products. A second important goal is to understand the nature of the interaction between the 5' and 3' termini, which may also be critical for efficient translation.

Mesh:

Substances:

Year:  1995        PMID: 7736570     DOI: 10.1016/0092-8674(95)90326-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  220 in total

1.  Recognition of yeast mRNAs as "nonsense containing" leads to both inhibition of mRNA translation and mRNA degradation: implications for the control of mRNA decapping.

Authors:  D Muhlrad; R Parker
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

2.  UTRdb and UTRsite: specialized databases of sequences and functional elements of 5' and 3' untranslated regions of eukaryotic mRNAs.

Authors:  G Pesole; S Liuni; G Grillo; F Licciulli; A Larizza; W Makalowski; C Saccone
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

3.  Splicing and 3' end formation in the definition of nonsense-mediated decay-competent human beta-globin mRNPs.

Authors:  G Neu-Yilik; N H Gehring; R Thermann; U Frede; M W Hentze; A E Kulozik
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

4.  Delivering messages from the 3' end.

Authors:  G Varani
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

Review 5.  mRNA surveillance in eukaryotes: kinetic proofreading of proper translation termination as assessed by mRNP domain organization?

Authors:  P Hilleren; R Parker
Journal:  RNA       Date:  1999-06       Impact factor: 4.942

6.  quick-to-court, a Drosophila mutant with elevated levels of sexual behavior, is defective in a predicted coiled-coil protein.

Authors:  P Gaines; L Tompkins; C T Woodard; J R Carlson
Journal:  Genetics       Date:  2000-04       Impact factor: 4.562

7.  Direct observation of specific messenger RNA in a single living cell under a fluorescence microscope.

Authors:  A Tsuji; H Koshimoto; Y Sato; M Hirano; Y Sei-Iida; S Kondo; K Ishibashi
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

8.  The length of the combined 3' untranslated region and poly(A) tail does not control rates of glyceraldehyde-3-phosphate dehydrogenase mRNA translation in three species of parasitic protists.

Authors:  B H ter Kuile; F J Sallés
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

9.  Fip1 regulates the activity of Poly(A) polymerase through multiple interactions.

Authors:  S Helmling; A Zhelkovsky; C L Moore
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

10.  Structure and function of a cap-independent translation element that functions in either the 3' or the 5' untranslated region.

Authors:  L Guo; E Allen; W A Miller
Journal:  RNA       Date:  2000-12       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.